Enrique Jiménez Chavarría

Suggest Changes
Learn More
BACKGROUND Octreotide is generally administered based on the surgeon's interpretation of perceived risk for pancreatic fistula at the time of pancreaticoduodenectomy (PD). METHODS A(More)
BACKGROUND Non-functional endocrine pancreatic tumours (NPT) of more than 2 cm have an increased risk of malignancy. The aim of the present study was: (i) to define the guidelines for laparoscopic(More)
  • 1